Efthymios (Makis) Papataxiarchis, Managing Director of Janssen Pharmaceutical companies, Johnson & Johnson Greece, Malta & Cyprus, on spearheading a large multinational company through the largest economic crisis in Europe. He speaks about Janssen’s portfolio in Greece, how to mitigate challenges in market access, as well as igniting a solutions-driven dialogue across the industry.
Mr. Papataxiarchis you recently marked one year since assuming the position as CEO of Janssen Greece. What have been your main accomplishments in your first year of leading the company, especially in a time of crisis?
"By igniting a solutions-driven dialogue we can stabilize the industry, promoting sustainability which will in turn attract investments, assisting in the improvement of healthcare and the economy as a whole."
